Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding

13.12.2019 17:45

HOCHDORF Group Press Release: Closing of the sale of Pharmalys Laboratories SA

Hochdorf, 13 December 2019  – With all pre-conditions met for the sale of the 51% shares in companies of the Pharmalys Group to Pharmalys Invest Holding, the closing has been completed today. The HOCHDORF Group is thus completing an important step towards financial recovery and increasing its strategic flexibility.

 

Contact:
Dr Christoph Hug, Head of Corporate Communications HOCHDORF Group, Tel:+41 (0)41 914 65 62 / +41 (0)79 859 19 23, christoph.hug@hochdorf.com.

 

 

About the HOCHDORF Group:
The HOCHDORF Group, based in Hochdorf, achieved a consolidated gross sales revenue of CHF 561.0 million in 2018. It is one of the leading foodstuff companies in Switzerland, employing over 694 staff as of 31.12.2018.Made from natural ingredients such as milk, wheat germ and oil seeds, HOCHDORF products have been contributing to our health and wellbeing since 1895 – from babies to senior citizens. Its customers include the food industry and the wholesale and retail sectors. Its products are sold in over 90 countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528).